Carl‐Wilhelm Vogel

2.9k total citations
94 papers, 2.2k citations indexed

About

Carl‐Wilhelm Vogel is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Carl‐Wilhelm Vogel has authored 94 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Immunology, 27 papers in Molecular Biology and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Carl‐Wilhelm Vogel's work include Complement system in diseases (48 papers), Monoclonal and Polyclonal Antibodies Research (25 papers) and Erythrocyte Function and Pathophysiology (24 papers). Carl‐Wilhelm Vogel is often cited by papers focused on Complement system in diseases (48 papers), Monoclonal and Polyclonal Antibodies Research (25 papers) and Erythrocyte Function and Pathophysiology (24 papers). Carl‐Wilhelm Vogel collaborates with scholars based in United States, Germany and France. Carl‐Wilhelm Vogel's co-authors include Hans J. Müller‐Eberhard, David C. Fritzinger, C A Smith, Reinhard Bredehorst, R Bredehorst, Markus Ollert, Eugene C. Petrella, Michael K. Pangburn, Kerstin A. David and Michael Andreas Kock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Carl‐Wilhelm Vogel

94 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl‐Wilhelm Vogel United States	29	1.2k	624	517	349	347	94	2.2k
Thomas Hoffman United States	25	1.5k 1.2×	1.0k 1.6×	271 0.5×	207 0.6×	201 0.6×	74	2.9k
Alister W. Dodds United Kingdom	33	2.5k 2.0×	759 1.2×	181 0.4×	626 1.8×	243 0.7×	66	3.4k
Carmen W. van den Berg United Kingdom	31	745 0.6×	1.1k 1.8×	1.1k 2.1×	208 0.6×	296 0.9×	79	2.7k
G. Larry Gartland United States	30	2.5k 2.0×	621 1.0×	194 0.4×	247 0.7×	148 0.4×	49	3.4k
Kevin L. Holmes United States	32	1.8k 1.5×	998 1.6×	338 0.7×	232 0.7×	99 0.3×	68	3.2k
Philip G. Ashton‐Rickardt United States	29	3.4k 2.7×	1.2k 1.9×	364 0.7×	209 0.6×	155 0.4×	57	4.5k
T E Mandel Australia	35	1.9k 1.5×	780 1.3×	1.4k 2.6×	205 0.6×	190 0.5×	160	4.2k
Tzvete Dentchev United States	28	695 0.6×	1.0k 1.6×	143 0.3×	210 0.6×	117 0.3×	44	2.3k
Lars Rogge France	33	2.8k 2.3×	1.2k 1.9×	560 1.1×	299 0.9×	301 0.9×	77	4.5k
R. G. Miller Canada	36	3.0k 2.4×	985 1.6×	289 0.6×	366 1.0×	132 0.4×	97	4.3k

Countries citing papers authored by Carl‐Wilhelm Vogel

Since Specialization

Citations

This map shows the geographic impact of Carl‐Wilhelm Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl‐Wilhelm Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl‐Wilhelm Vogel more than expected).

Fields of papers citing papers by Carl‐Wilhelm Vogel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl‐Wilhelm Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl‐Wilhelm Vogel. The network helps show where Carl‐Wilhelm Vogel may publish in the future.

Co-authorship network of co-authors of Carl‐Wilhelm Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Carl‐Wilhelm Vogel. A scholar is included among the top collaborators of Carl‐Wilhelm Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl‐Wilhelm Vogel. Carl‐Wilhelm Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pangburn, Michael K., et al.. (2020). Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability. Toxicon. 184. 68–77. 1 indexed citations

Guerrero, Rachael T. Leon, et al.. (2019). A Unique Partnership Between the University of Hawai'i Cancer Center and the University of Guam: Fifteen Years of Addressing Cancer Health Disparities in Pacific Islanders in Hawai'i and Guam.. PubMed. 78(6). 205–207. 1 indexed citations

Fritzinger, David C., et al.. (2019). Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins. Toxicon. 167. 106–116. 1 indexed citations

Vogel, Carl‐Wilhelm, et al.. (2014). University of Hawai'i Cancer Center Connection: regional cooperation in addressing cancer health disparities: NCI's Geographic Management Program (GMaP) and Biospecimen Management Program (BMaP) in Western States, Hawai'i, and US pacific territories.. Europe PMC (PubMed Central). 3 indexed citations

Fritzinger, David C., et al.. (2012). Hybrid proteins of Cobra Venom Factor and cobra C3: Tools to identify functionally important regions in Cobra Venom Factor. Toxicon. 60(4). 632–647. 8 indexed citations

Cooney, Robert V., John A. Burns, & Carl‐Wilhelm Vogel. (2012). Modern Medicine and the Road to Prevention: A Long and Tortuous Path. 1 indexed citations

Fritzinger, David C., et al.. (2010). Complement Depletion with Humanized Cobra Venom Factor in a Mouse Model of Age-Related Macular Degeneration. Advances in experimental medicine and biology. 703. 151–162. 15 indexed citations

Juhl, Hartmut, Eugene C. Petrella, Nai‐Kong V. Cheung, Reinhard Bredehorst, & Carl‐Wilhelm Vogel. (1997). Title>Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells. Immunobiology. 197(5). 444–459. 21 indexed citations

Erttmann, R., Caroline Schmitt, Markus Ollert, et al.. (1996). Naturally Occurring Humoral Cytotoxicity Against Neuroblastoma (NB) Cells in Healthy Persons and Nb Patients. Pediatric Hematology and Oncology. 13(6). 545–548. 6 indexed citations

10.

Pomato, Nicholas, et al.. (1995). Cobra venom factor immunoconjugates: effects of carbohydrate-directed versus amino group-directed conjugation. Bioconjugate Chemistry. 6(4). 367–372. 8 indexed citations

11.

Gowda, D. Channe, Eugene C. Petrella, Reinhard Bredehorst, & Carl‐Wilhelm Vogel. (1993). Correction to Abstract 8.09 from the Twenty-First Annual Meeting of the Society for Complex Carbohydrates. Glycobiology. 3(3). 192–192. 1 indexed citations

12.

Fritzinger, David C., et al.. (1992). Primary structure of cobra complement component C3. The Journal of Immunology. 149(11). 3554–3562. 50 indexed citations

13.

Wood, Richard D., et al.. (1991). A carbohydrate-directed heterobifunctional cross-linking reagent for the synthesis of immunoconjugates. Analytical Biochemistry. 194(1). 156–162. 29 indexed citations

14.

Ollert, Markus, Raymond Frade, Eugene C. Petrella, et al.. (1990). C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells.. The Journal of Immunology. 144(10). 3862–3867. 36 indexed citations

15.

Juhl, Hartmut, Eugene C. Petrella, Nai‐Kong V. Cheung, Reinhard Bredehorst, & Carl‐Wilhelm Vogel. (1990). Complement killing of human neuroblastoma cells: A cytotoxic monoclonal antibody and its F(ab)'2-cobra venom factor conjugate are equally cytotoxic. Molecular Immunology. 27(10). 957–964. 33 indexed citations

16.

Vogel, Carl‐Wilhelm. (1988). Synthesis of antibody conjugates with cobra venom factor using heterobifunctional cross-linking reagents.. PubMed. 1. 191–224. 2 indexed citations

17.

Vogel, Carl‐Wilhelm. (1987). Immunoconjugates : antibody conjugates in radioimaging and therapy of cancer. Oxford University Press eBooks. 60 indexed citations

18.

Ligler, Frances S., Reinhard Bredehorst, Charles F. Hammer, et al.. (1987). A homogeneous immunoassay for the mycotoxin T-2 utilizing liposomes, monoclonal antibodies, and complement. Analytical Biochemistry. 163(2). 369–375. 29 indexed citations

19.

Welt, S, et al.. (1986). A molecular mechanism of complement resistance of human melanoma cells.. The Journal of Immunology. 136(7). 2534–2541. 23 indexed citations

20.

Smith, C A, Carl‐Wilhelm Vogel, & Hans J. Müller‐Eberhard. (1984). MHC Class III products: an electron microscopic study of the C3 convertases of human complement.. The Journal of Experimental Medicine. 159(1). 324–329. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact